Amicus Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -7.26M-54.94M-44.41M-48.78M-59.63M-68.93M-132.12M-200.04M-284.00M-349.00M-356.39M-276.85M-250.46M-236.57M-151.58M-56.11M
Depreciation and Depletion 1.55M1.83M3.24M3.60M4.20M4.50M8.40M5.70M4.80M4.80M5.00M
Share-based Compensation 7.79M6.19M8.68M6.19M6.18M6.01M9.97M17.50M23.10M29.26M44.43M49.15M57.84M76.51M86.08M84.91M
Deferred Taxes -1.29M-1.42M-0.15M0.03M0.01M-4.94M
Gains from Sales and Divestitures 0.28M0.32M
Gains from Investment Securities -0.20M-0.12M-2.76M-0.65M-0.91M0.10M4.38M6.76M-234.32M3.30M3.30M10.37M20.03M11.49M17.92M22.02M
Asset Writedowns and Impairment 1.03M2.22M465.43M0.10M18.18M2.73M9.21M
Non-cash Items 7.30M7.70M33.70M105.80M
Cash from Operations -43.37M-13.98M-49.42M-33.74M-45.79M-51.67M-100.14M-150.15M-213.69M-299.95M-250.42M-233.29M-202.49M-166.57M-69.09M-33.89M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.53M0.53M0.28M0.49M2.69M9.70M10.98M2.55M1.79M2.49M2.63M2.62M2.26M
Depreciation & Amortization (CF) 2.13M2.06M1.58M1.71M1.72M1.55M1.83M3.24M3.59M4.22M4.78M8.85M6.21M5.34M7.87M8.55M
Change in Working Capital
Change in Receivables 1.42M7.72M13.29M11.11M11.22M8.19M17.33M20.11M19.48M
Change in Inventory 3.65M0.90M4.21M5.11M4.64M7.79M5.34M44.61M73.65M
Change in Accured Expenses 0.84M-1.34M1.42M-0.86M-0.61M6.17M15.47M7.13M12.56M17.11M46.74M-10.61M7.43M-6.38M49.20M-16.52M
Other Working Capital Changes -47.74M32.28M-4.78M-3.63M6.26M-2.29M0.67M0.97M15.33M-2.49M3.29M8.77M5.92M6.19M8.06M-13.96M
Investing Activities
Capital Expenditures -1.81M0.38M1.42M4.32M0.69M0.24M4.82M5.95M4.53M6.31M20.01M3.23M3.88M3.77M7.44M3.55M
Sales of Property, Plant and Equipment 3.41M
Acquisitions 141.06M
Change in Acquisitions & Divestments 131.85M94.60M98.47M83.35M83.34M55.91M290.13M221.37M323.75M463.50M499.05M354.83M424.04M335.93M197.23M117.78M
Cash from Investing Activities 31.87M-19.44M46.45M-39.43M26.08M-107.08M-145.34M-4.51M-171.24M-121.20M95.15M-13.58M78.76M92.32M98.06M-0.56M
Financing Activities
Other financing activities 8.68M6.19M6.18M6.01M9.97M17.50M23.10M
Cash from Financing Activities 2.77M43.66M-0.93M81.48M29.38M139.18M290.89M272.71M247.43M450.77M217.50M262.86M212.07M-7.46M61.68M5.12M
Additional items
Exchange Rate Effect -0.13M1.33M1.52M1.73M3.83M-5.05M-14.62M6.31M-4.03M
Change in Cash -8.73M10.23M-3.90M8.30M9.67M-19.57M45.41M117.93M-136.18M31.14M63.97M19.82M83.29M-96.34M96.96M-33.36M
Free Cash Flow -41.56M-14.37M-50.84M-38.07M-46.49M-51.91M-104.96M-156.10M-218.22M-306.26M-270.43M-236.52M-206.38M-170.34M-76.53M-37.44M
Net Cash Flow -8.73M10.23M-3.90M8.30M9.67M-19.57M45.41M118.06M-137.50M29.62M62.24M15.99M88.34M-81.72M90.65M-29.33M